Negative feedback and adaptive resistance to the targeted therapy of cancer

av Chandarlapaty, Sarat
Publicerad 2012

Ash1, a Daughter Cell-Specific Protein, Is Required for Pseudohyphal Growth of Saccharomyces cerevisiae

av Chandarlapaty, Sarat, Errede, Beverly
Publicerad 1998

HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies

av Gajria, Devika, Chandarlapaty, Sarat
Publicerad 2011

Molecular Pathways: HER3 targeted therapy

av Gala, Kinisha, Chandarlapaty, Sarat
Publicerad 2014

Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors

av Chandarlapaty, Sarat, Razavi, Pedram
I publikationen J Clin Oncol (2019)

Unlocking the potential of antibody–drug conjugates for cancer therapy

av Drago, Joshua Z., Modi, Shanu, Chandarlapaty, Sarat
I publikationen Nat Rev Clin Oncol (2021)

ESR1 and endocrine therapy resistance: more than just mutations

av Piscuoglio, S, Ng, C K Y, Weigelt, B, Chandarlapaty, S, Reis-Filho, J S
I publikationen Ann Oncol (2018)

A new approach to parathyroidectomy.

av Irvin, G L, Prudhomme, D L, Deriso, G T, Sfakianakis, G, Chandarlapaty, S K
Publicerad 1994

Structural Underpinnings of Estrogen Receptor Mutations in Endocrine Therapy Resistance

av Katzenellenbogen, John A., Mayne, Christopher G., Katzenellenbogen, Benita S., Greene, Geoffrey L., Chandarlapaty, Sarat
I publikationen Nat Rev Cancer (2018)

PTEN is a protein tyrosine phosphatase for IRS1

av Shi, Yuji, Wang, Junru, Chandarlapaty, Sarat, Cross, Justin, Thompson, Craig, Rosen, Neal, Jiang, Xuejun
Publicerad 2014

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

av Yang, C, Li, Z, Bhatt, T, Dickler, M, Giri, D, Scaltriti, M, Baselga, J, Rosen, N, Chandarlapaty, S
I publikationen Oncogene (2017)

Head-to-Head Evaluation of (18)F-FES and (18)F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer

av Ulaner, Gary A., Jhaveri, Komal, Chandarlapaty, Sarat, Hatzoglou, Vaios, Riedl, Christopher C., Lewis, Jason S., Mauguen, Audrey
I publikationen J Nucl Med (2021)

Protocol for PTEN Expression by Immunohistochemistry in Formalin-fixed Paraffin-embedded Human Breast Carcinoma

av Sakr, Rita A., Barbashina, Violetta, Morrogh, Mary, Chandarlapaty, Sarat, Andrade, Victor P., Arroyo, Crispinita D., Olvera, Narciso, King, Tari A.
Publicerad 2010

Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel

av Sawai, Ayana, Chandarlapaty, Sarat, Greulich, Heidi, Gonen, Mithat, Ye, Qing, Arteaga, Carlos L., Sellers, William, Rosen, Neal, Solit, David B.
Publicerad 2008

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

av Chandarlapaty, Sarat, Sawai, Ayana, Scaltriti, Maurizio, Rodrik-Outmezguine, Vanessa, Grbovic-Huezo, Olivera, Serra, Violeta, Majumder, Pradip K., Baselga, Jose, Rosen, Neal
Publicerad 2011

mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling

av Rodrik-Outmezguine, Vanessa S., Chandarlapaty, Sarat, Pagano, Nen C., Poulikakos, Poulikos I., Scaltriti, Maurizio, Moskatel, Elizabeth, Baselga, José, Guichard, Sylvie, Rosen, Neal
Publicerad 2011

Association of PI3K Pathway Mutations with Early PET/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single Center Retrospective Pilot...

av Deipolyi, Amy R., Riedl, Christopher, Bromberg, Jacqueline, Chandarlapaty, Sarat, Klebanoff, Christopher, Sofocleous, Constantinos, Yarmohammadi, Hooman, Brody, Lynn, Boas, F. Edward, Ziv, Etay
I publikationen J Vasc Interv Radiol (2018)

Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up

av Wang, Rui, Smyth, Lillian M., Iyengar, Neil, Chandarlapaty, Sarat, Modi, Shanu, Jochelson, Maxine, Patil, Sujata, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
I publikationen Oncologist (2019)

Potent and Preferential Degradation of CDK6 via PROteolysis TArgeting Chimera Degraders

av Su, Shang, Yang, Zimo, Gao, Hongying, Yang, Haiyan, Zhu, Songbiao, An, Zixuan, Wang, Juanjuan, Li, Qing, Chandarlapaty, Sarat, Deng, Haiteng, Wu, Wei, Rao, Yu
I publikationen J Med Chem (2019)

Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

av Lidia Mateo, Miquel Duran-Frigola, Albert Gris-Oliver, Marta Palafox, Maurizio Scaltriti, Pedram Razavi, Sarat Chandarlapaty, Joaquin Arribas, Meritxell Bellet, Violeta Serra, Patrick Aloy
Publicerad 2020-09-01